CSIMarket
 


Celularity Inc   (CELU)
Other Ticker:  
 
 

CELU's Operating Income Growth by Quarter and Year

Celularity Inc 's Operating Income results by quarter and year




CELU Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 17.49 -9.36 0.00
III Quarter September -99.26 -5.65 10.90 0.00
II Quarter June -42.48 4.18 -1.54 0.00
I Quarter March -63.87 -41.61 0.00 0.00
FY   -205.61 -25.59 0.00 0.00



CELU Operating Income third quarter 2023 Y/Y Growth Comment
Celularity Inc in the third quarter 2023 recorded Operating Loss of $ -99.26 millions.

According to the results reported in the third quarter 2023, Celularity Inc achieved the best Operating Income growth in Major Pharmaceutical Preparations industry. While Celularity Inc ' s Operating Income no change of % ranks overall at the positon no. in the third quarter 2023.

Explain Operating Income growth


CELU Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Celularity Inc 's third quarter 2023 Operating Income $ -99.26 millions CELU's Income Statement
Celularity Inc 's third quarter 2022 Operating Income $ -5.65 millions Quarterly CELU's Income Statement
New: More CELU's historic Operating Income Growth >>


CELU Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Celularity Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELU's III. Quarter Q/Q Operating Income Comment
III. Quarter 2023 accomplishment of -99.26 millions by Celularity Inc come out even more unfavourable compare to the -42.48 millions Operating Loss a quarter before.

Within Major Pharmaceutical Preparations industry Celularity Inc achieved highest sequential Operating Income growth. While Celularity Inc 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CELU's III. Quarter Q/Q Operating Income Comment
Recent Operating Loss of -99.26 millions by Celularity Inc come out even less good if you take a look at -42.48 millions Operating Loss in the second quarter.

Within Major Pharmaceutical Preparations industry Celularity Inc achieved highest sequential Operating Income growth. While Celularity Inc 's Operating Income growth quarter on quarter, overall rank is .


Celularity Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Operating Income 12 Months Ending $ -188.12 $ -94.51 $ -47.86 $ -25.60 $ -52.44
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Celularity Inc ' has realized cumulative trailing twelve months Operating Loss of $ -188 millions in the Sep 30 2023 period.
The business is getting worse as the cumulative Operating Loss is getting bigger from $ -94.51 millions in the twelve months ending a quarter before and $ -35.900319 millions for the twelve months ending in the quarter a year ago.

Celularity Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Celularity Inc ' has realized cumulative trailing twelve months Operating Loss of $ -188 millions in the Sep 30 2023 period.
The business is detiriorating as the cumulative Operating Loss is getting bigger from $ -94.51 millions for the period from Jun 30 2023 to Sep 30 2022 and $ -35.900319 millions from the TTM period ending Sep 30 2022 Hugo Sánchez wrote.

Celularity Inc achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CELU's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CELU's Competitors
Operating Income Growth for Celularity Inc 's Suppliers
Operating Income Growth for CELU's Customers

You may also want to know
CELU's Annual Growth Rates CELU's Profitability Ratios CELU's Asset Turnover Ratio CELU's Dividend Growth
CELU's Roe CELU's Valuation Ratios CELU's Financial Strength Ratios CELU's Dividend Payout Ratio
CELU's Roa CELU's Inventory Turnover Ratio CELU's Growth Rates CELU's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Sep 30 2023
Insulet Corporation1,789.66%$ 1,789.655 millions
Orasure Technologies Inc1,145.03%$ 1,145.029 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com